Science, Technology, Investor Reception
“How Patients are Driving Innovation in the Future Healthcare Environment ”
Dr. Karin Hehenberger is the founder of Lyfebulb, a business focused on bridging patient communities with industry and providing a strong voice to people living with chronic disease by empowering patient entre-preneurs. Diagnosed with type 1 diabetes at an early age, Dr. Hehen-berger has dedicated her life to helping others impacted by chronic ill-nesses. Her personal history with diabetes as well as its consequences, which required kidney and pancreas transplants, provide Dr. Hehen-berger with an understanding from a patient perspective as well as a med-ical professional. It is from those experiences both as a patient and as a doctor, that Dr. Hehenberger was motivated to create Lyfebulb.
Wednesday, October 25, 2017
Greehey Children’s Cancer Research Institute (GCCRI); 8403 Floyd Curl Drive, San Antonio, TX 78229
Source: UT Health San Antonio
Press Contact for Lyfebulb: Shepard Doniger BDCG, Inc. 561-637-5750 email@example.com